| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidase activity | 2.04e-04 | 654 | 38 | 7 | GO:0008233 | |
| Domain | TSP_1 | 1.49e-07 | 63 | 37 | 5 | PF00090 | |
| Domain | TSP1 | 1.75e-07 | 65 | 37 | 5 | SM00209 | |
| Domain | TSP1_rpt | 1.75e-07 | 65 | 37 | 5 | IPR000884 | |
| Domain | TSP1 | 1.75e-07 | 65 | 37 | 5 | PS50092 | |
| Domain | PRKG1_interact | 1.14e-05 | 3 | 37 | 2 | IPR031775 | |
| Domain | PRKG1_interact | 1.14e-05 | 3 | 37 | 2 | PF15898 | |
| Domain | MYPT1/MYPT2_chordates | 1.14e-05 | 3 | 37 | 2 | IPR017401 | |
| Domain | ADAM_spacer1 | 1.23e-05 | 23 | 37 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.23e-05 | 23 | 37 | 3 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.41e-05 | 24 | 37 | 3 | IPR013273 | |
| Domain | PLAC | 3.42e-04 | 14 | 37 | 2 | PF08686 | |
| Domain | VWC_out | 6.39e-04 | 19 | 37 | 2 | SM00215 | |
| Domain | PLAC | 6.39e-04 | 19 | 37 | 2 | IPR010909 | |
| Domain | PLAC | 6.39e-04 | 19 | 37 | 2 | PS50900 | |
| Domain | TRYPSIN_SER | 7.47e-04 | 90 | 37 | 3 | IPR033116 | |
| Domain | TRYPSIN_HIS | 1.10e-03 | 103 | 37 | 3 | IPR018114 | |
| Domain | TRYPSIN_SER | 1.20e-03 | 106 | 37 | 3 | PS00135 | |
| Domain | TRYPSIN_HIS | 1.23e-03 | 107 | 37 | 3 | PS00134 | |
| Domain | Peptidase_S1A | 1.44e-03 | 113 | 37 | 3 | IPR001314 | |
| Domain | TRYPSIN_DOM | 1.52e-03 | 115 | 37 | 3 | PS50240 | |
| Domain | Tryp_SPc | 1.59e-03 | 117 | 37 | 3 | SM00020 | |
| Domain | Trypsin | 1.75e-03 | 121 | 37 | 3 | PF00089 | |
| Domain | Trypsin_dom | 1.75e-03 | 121 | 37 | 3 | IPR001254 | |
| Domain | Peptidase_S1_PA | 1.84e-03 | 123 | 37 | 3 | IPR009003 | |
| Domain | VWFC_1 | 2.31e-03 | 36 | 37 | 2 | PS01208 | |
| Domain | VWC | 2.57e-03 | 38 | 37 | 2 | SM00214 | |
| Domain | VWFC_2 | 2.57e-03 | 38 | 37 | 2 | PS50184 | |
| Domain | Peptidase_M12B_N | 2.70e-03 | 39 | 37 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.70e-03 | 39 | 37 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 2.84e-03 | 40 | 37 | 2 | PS00427 | |
| Domain | ADAM_MEPRO | 2.84e-03 | 40 | 37 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.84e-03 | 40 | 37 | 2 | PS50214 | |
| Domain | Reprolysin | 2.84e-03 | 40 | 37 | 2 | PF01421 | |
| Domain | Peptidase_M12B | 2.84e-03 | 40 | 37 | 2 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 2.98e-03 | 41 | 37 | 2 | PS00546 | |
| Domain | Disintegrin_dom | 2.98e-03 | 41 | 37 | 2 | IPR001762 | |
| Domain | VWF_dom | 3.13e-03 | 42 | 37 | 2 | IPR001007 | |
| Domain | Pept_M10_metallopeptidase | 3.28e-03 | 43 | 37 | 2 | IPR001818 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.11e-07 | 39 | 24 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 5.11e-07 | 39 | 24 | 4 | MM15165 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.89e-06 | 68 | 24 | 4 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.19e-05 | 109 | 24 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.43e-05 | 111 | 24 | 4 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 9.21e-05 | 143 | 24 | 4 | M27275 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 7.76e-04 | 250 | 24 | 4 | M27554 | |
| Pubmed | 2.53e-08 | 75 | 40 | 5 | 20637190 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 16243315 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 16507336 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 22562232 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 12923170 | ||
| Pubmed | 8.45e-05 | 12 | 40 | 2 | 24785407 | ||
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 30579834 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.39e-04 | 1105 | 40 | 7 | 35748872 | |
| Pubmed | 2.94e-04 | 22 | 40 | 2 | 21750033 | ||
| Pubmed | 5.13e-04 | 29 | 40 | 2 | 24971735 | ||
| Pubmed | 5.13e-04 | 29 | 40 | 2 | 24909139 | ||
| Pubmed | 5.50e-04 | 30 | 40 | 2 | 19054571 | ||
| Pubmed | 5.50e-04 | 30 | 40 | 2 | 17257418 | ||
| Pubmed | Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly. | 8.83e-04 | 38 | 40 | 2 | 36674791 | |
| Pubmed | 9.79e-04 | 40 | 40 | 2 | 17199044 | ||
| Pubmed | 1.11e-03 | 1431 | 40 | 7 | 37142655 | ||
| Cytoband | 16p13.3 | 1.27e-03 | 244 | 40 | 3 | 16p13.3 | |
| GeneFamily | Proteases, serine | 5.13e-05 | 63 | 21 | 3 | 738 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.17e-04 | 19 | 21 | 2 | 50 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.85e-02 | 181 | 21 | 2 | 694 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.63e-07 | 191 | 40 | 5 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.83e-07 | 192 | 40 | 5 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.94e-05 | 178 | 40 | 4 | 3c973aac16988e88f5677d3d695dd772ccfd6570 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.07e-05 | 181 | 40 | 4 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.07e-05 | 181 | 40 | 4 | 70eff83dd85691e977972c660731394d2fcf5cdf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3-6_VIP_KCTD13|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 183 | 40 | 4 | f06c06c75aab55fa8c803665afaa399446aec5af | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-05 | 184 | 40 | 4 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.35e-05 | 187 | 40 | 4 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 188 | 40 | 4 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 188 | 40 | 4 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 191 | 40 | 4 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-05 | 192 | 40 | 4 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | Sepsis-Int-URO-Others-RBC|Int-URO / Disease, condition lineage and cell class | 2.94e-05 | 198 | 40 | 4 | 29203aaa5c1844f72289e03f585cd5e7fc498a9a | |
| ToppCell | Sepsis-Int-URO-Others|Int-URO / Disease, condition lineage and cell class | 2.94e-05 | 198 | 40 | 4 | 67f721ea8e60042317ba12efd584f56b07cfb29d | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_Myelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.00e-05 | 199 | 40 | 4 | 2b567b6fd8addf059bbf2b72c55a7647aefdc595 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.00e-05 | 199 | 40 | 4 | 4e4bdcd2e8b518156d5ebd294804180acaa3566b | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 48303e499251d6754cfa991dc2d96c5563b2123c | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | f922f9f223cbfed71b8e3115b16b51dc4d7b66b8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 7e51715525fdb001b7042b2bfcb9de81ecb5e4ee | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 4802dd6cae84b41746227a5d1aa1c9b858495e36 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | c4e08cf539c12bb7c61be6d44b4f074bb460f526 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 913487e065dd580c9cbcbb3c3fc76a8d446f8856 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 75649534a98bc738fca62d071de0978dc61eb24f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 116 | 40 | 3 | a07f16917c66ce25f23ebef350d693cc4c324075 | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.96e-04 | 126 | 40 | 3 | 333f83f9ba64d46f22fee328d0a691fd5818bdac | |
| ToppCell | Thalamus-Endothelial-MURAL|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.96e-04 | 126 | 40 | 3 | cf571f36761da3540fb445de89d555cbce8a47ab | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.79e-04 | 142 | 40 | 3 | 94e277f038f4006d99ff50222b0f5cf89bc3d46d | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar-Club_cell|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.21e-04 | 149 | 40 | 3 | 82edfecb7981d8c336cf9da7aa7e2b3f7a017a3f | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.21e-04 | 149 | 40 | 3 | 14a01ae540db8a350ea26a350b2e6ce6c07639d9 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.75e-04 | 157 | 40 | 3 | 5aee90ad7aaa65fdabc23597451da5e48db8f4e6 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.75e-04 | 157 | 40 | 3 | 9665a1375cfd8e9b8781c852686591226c0e0d9a | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 160 | 40 | 3 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 160 | 40 | 3 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 160 | 40 | 3 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-04 | 161 | 40 | 3 | 0d863d7d369391dd6148e1de6d6f8033dcb8fe0f | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-hematologic-erythrocytic-erythrocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.11e-04 | 162 | 40 | 3 | 25a11e4c6304324310b33a33331ebc812d045d4a | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.25e-04 | 164 | 40 | 3 | 85f53d184fa70e3eb1af655807f32b17ddbfb304 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.25e-04 | 164 | 40 | 3 | 144ba070a1ede71684224cc6d4ead3b7e6a7b4c6 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-04 | 166 | 40 | 3 | a2ce44702a0cd5fa5872cac3302d3c451205feef | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-04 | 166 | 40 | 3 | 0f641302a6b71c4badaaf20f51162bfc2386b167 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 167 | 40 | 3 | cf6206c506715cd846799c62cf7c06e3fa99f7af | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.49e-04 | 167 | 40 | 3 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.56e-04 | 168 | 40 | 3 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 169 | 40 | 3 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.81e-04 | 171 | 40 | 3 | 3a2fefcb62e9d47ae6b3a946c45d3f2dd32c576c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.81e-04 | 171 | 40 | 3 | 3ef44a5e3e8f81424f1e9aa302860b6688a549b8 | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 4.89e-04 | 172 | 40 | 3 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-04 | 174 | 40 | 3 | fdadac1eaab2c4a67e4832f0901df22e893add6a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-04 | 174 | 40 | 3 | 8d8cf8ad17dcc364f867e36b10834a21c0e36ad2 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.06e-04 | 174 | 40 | 3 | ca067e8ec55bbc3deafc09f08bc13af08364d165 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM4|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.06e-04 | 174 | 40 | 3 | 9191f6abb37ca65da5105f91e21689d11ec1059b | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM4-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.06e-04 | 174 | 40 | 3 | fe105550a43b935affc73e32796115d20328a2f8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.14e-04 | 175 | 40 | 3 | e78bf0c33a741bb97e987e41ac33da9e623a08ec | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.14e-04 | 175 | 40 | 3 | 5a9160a9d05e01d945e77fd81bb0bd87139545cd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.23e-04 | 176 | 40 | 3 | 23f930dac5247ea6d4124da33933d61ad6e089af | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.23e-04 | 176 | 40 | 3 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.40e-04 | 178 | 40 | 3 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-04 | 178 | 40 | 3 | 24e8c62060455159235985f456af0c5023a7f3f5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-04 | 178 | 40 | 3 | 4f1cc954d4d9b5b2b75a4cf995ba81e2ada27084 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.49e-04 | 179 | 40 | 3 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.49e-04 | 179 | 40 | 3 | 01302505816f272243659e20d751b61a198a2fc0 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.49e-04 | 179 | 40 | 3 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.49e-04 | 179 | 40 | 3 | 5bf191bdc0c32bce83ab5c38f0616e209e420e55 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-B_memory-0|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.49e-04 | 179 | 40 | 3 | fce1ba53815145f6248d4e90aedca3dad84e33e4 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.49e-04 | 179 | 40 | 3 | dfd5b25f2a6a5a8bf4714f1516cb0997de72b06f | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 5.67e-04 | 181 | 40 | 3 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.67e-04 | 181 | 40 | 3 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-04 | 182 | 40 | 3 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 5.76e-04 | 182 | 40 | 3 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 5.76e-04 | 182 | 40 | 3 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.76e-04 | 182 | 40 | 3 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-04 | 182 | 40 | 3 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 5.76e-04 | 182 | 40 | 3 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.76e-04 | 182 | 40 | 3 | 0346f81bbb1f309f3e9d063b20547d548d09472c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-04 | 182 | 40 | 3 | 1e2149b222a3e9f64841aed45288a6f29394e7b0 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.76e-04 | 182 | 40 | 3 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-04 | 182 | 40 | 3 | d1a1feef318062f25493355d7beee8e5fb0e4206 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-04 | 183 | 40 | 3 | 06ac66726ec53db810ebb90ec69cfdb903da53f6 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-04 | 183 | 40 | 3 | 5f2db95d44b7de68779de098892892af540fd431 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-04 | 183 | 40 | 3 | 8d45dff06a199b1369576657f7f9dc0249c5f841 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.85e-04 | 183 | 40 | 3 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 5.85e-04 | 183 | 40 | 3 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-04 | 183 | 40 | 3 | 421265fa15d5a028cb567bb0904e670473ef102b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.95e-04 | 184 | 40 | 3 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.95e-04 | 184 | 40 | 3 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.95e-04 | 184 | 40 | 3 | 157a3d00165bb4a8c52c3e63ae57d9cf57500be7 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.95e-04 | 184 | 40 | 3 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-04 | 185 | 40 | 3 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-04 | 185 | 40 | 3 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.04e-04 | 185 | 40 | 3 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.04e-04 | 185 | 40 | 3 | 35d39a1d04c871edcfb749653538dc5fd0054281 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.04e-04 | 185 | 40 | 3 | 602536a3308a848f106adcb0a83530997440c8f4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-04 | 186 | 40 | 3 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-04 | 186 | 40 | 3 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-04 | 186 | 40 | 3 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.23e-04 | 187 | 40 | 3 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.23e-04 | 187 | 40 | 3 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.23e-04 | 187 | 40 | 3 | 6f7f293c9cf35261e0e3614e46ec1fb00a701b63 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.23e-04 | 187 | 40 | 3 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.23e-04 | 187 | 40 | 3 | 25efb82afe863a853ecdd781ad89026c993aaa67 | |
| Disease | major depressive disorder | 8.94e-04 | 155 | 36 | 3 | MONDO_0002009 | |
| Disease | kynurenine measurement | 1.04e-03 | 39 | 36 | 2 | EFO_0008529 | |
| Disease | cigarettes per day measurement | 1.94e-03 | 438 | 36 | 4 | EFO_0006525 | |
| Disease | Calcium channel blocker use measurement | 2.22e-03 | 213 | 36 | 3 | EFO_0009930 | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 2.70e-03 | 63 | 36 | 2 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | sclerosing cholangitis | 2.96e-03 | 66 | 36 | 2 | EFO_0004268 | |
| Disease | coronary artery disease | 2.98e-03 | 1194 | 36 | 6 | EFO_0001645 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NGAWGRPHLSHLTFW | 91 | P02730 | |
| GHIPPGHCLKSWSWN | 426 | P17405 | |
| HSFTPWIQAHGGWEG | 306 | Q9HB09 | |
| WEVHCWPSGTSGGTP | 41 | Q17RM4 | |
| AEWAGDKGGGWAPHH | 766 | Q5TGY3 | |
| GPKPTHGHWSDWSSW | 581 | Q8TE57 | |
| KHNRWSWGGSLHGSP | 156 | Q14244 | |
| WSLGSPLHFAGWHCS | 406 | Q09327 | |
| SCWSRGTPFPHGSSW | 871 | Q9Y219 | |
| KGHDGHRTPTWWLTG | 271 | Q9H9K5 | |
| SIHLPPNTHCWISGW | 166 | Q9GZN4 | |
| AGCVPATDPHSWWAG | 361 | P57737 | |
| QGLTELAWGTWPHSH | 36 | Q9Y6Z4 | |
| HWGEPKTWYGVPSHA | 496 | P29375 | |
| GTWPWQVSLHHGGGH | 56 | Q5K4E3 | |
| THACPHDAAWSTGPW | 1436 | Q9P2N4 | |
| SWYHQPWSPGSPGHG | 266 | A5D6W6 | |
| GLGGHWACSEPSPWT | 51 | A8MYX2 | |
| HWLDPSPWVHPTLHG | 291 | Q5VU57 | |
| WHWPEDSHPGLAGAS | 256 | Q5D0E6 | |
| AHLGPSEAQHWSHGW | 16 | O43555 | |
| HWTYEGPHGQDHWPA | 21 | Q9ULX7 | |
| HLGGIWAGHSPWTVI | 166 | O15255 | |
| WIDGWRSFNPGHEHP | 456 | Q8IZU8 | |
| LFHSLAWGSWTPGEG | 366 | Q14623 | |
| APLHLDVTWGWEHWG | 81 | Q96S19 | |
| RDGDGWTPLHAAAHW | 256 | Q9BZL4 | |
| EHPCTVYHWQTGPWG | 691 | Q9UPZ6 | |
| HWEHGQEWTTPGDPC | 261 | Q6ZWJ8 | |
| WHQASTPSGTWTGHG | 1071 | Q92540 | |
| SWFRPTHPGAEDGSW | 106 | Q3SY56 | |
| THPGAEDGSWWDLHP | 111 | Q3SY56 | |
| WDLHPGTSWMDLPHT | 121 | Q3SY56 | |
| GHFGVWSPWTPCTHT | 541 | Q13591 | |
| WEKPSGWGHLHAAVT | 81 | Q8N1V8 | |
| WSADPAAHLATHPWL | 791 | O15417 | |
| RPSPGFSWSHGSWSD | 301 | O95428 | |
| RCWVSGWGHTHPSHT | 341 | Q9H3S3 | |
| LPHWDSESLPHWGSE | 481 | Q9UQQ2 | |
| WSVDVGRHPGWTGHV | 1201 | Q86X10 | |
| GRHPGWTGHVSTSWS | 1206 | Q86X10 | |
| DTAHPHGGPSWWASL | 246 | Q6DKI7 | |
| HGGPSWWASLPTHAA | 251 | Q6DKI7 | |
| WWASLPTHAAHRPQG | 256 | Q6DKI7 | |
| DGWTPLHAAAHWGKE | 231 | O14974 | |
| SCSHDGLDGGWWAPP | 1196 | O15399 |